Pharma News: Vivus, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)’s Settled Stock & Amgen, Inc. (AMGN)’s Clinical Trial

Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN)

Pfizer Elected to Continue Development of Tamper-resistant Painkiller Remoxy – VIVUS, ARNA, ARIA, MNKD, MRK, PFE (FiscalInsider)
Investors in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) saw new options become available this week, for the April 2014 expiration. …VIVUS, Inc. (NASDAQ:VVUS) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. For Portfolio Grader’s specific subcategory of Equity, VVUS also gets an F. The stock price has dropped 6.1% over the past month, worse than the 1.3% decrease the NASDAQ has seen over the same period of time VIVUS, Inc. (NASDAQ:VVUS) shares plunged -0.81% to $12.23 in last trading session. Stock traded in range of $12.00 – $12.41.

VIVUS, Inc. (NASDAQ:VVUS)

Onyx trials cloud Amgen deal (TheDeal)
A Bloomberg article that ran Aug. 14 cited anonymous sources saying that Amgen, Inc. (NASDAQ:AMGN)‘s $10 billion, $120 per share acquisition of Onyx Pharmaceuticals Inc. was hanging on whether Amgen could see results of a clinical trial for Onyx’s Kyprolis. However, the reference to the study results was ambiguous and left parties tracking the deal trying to figure out which trial the sources were alluding to and whether access to the data could truly be a deal-breaker.

Biotech Stocks in News, VIVUS Inc, Arena Pharmaceuticals Inc, Ariad Pharmaceuticals Inc, MannKind Corporation, Affymax, Pfizer Inc (FiscalInsider)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a controversial stock among biotech investors. The bulls believe that increasing rates of global obesity will inevitably trigger more sales of its new weight loss drug, Belviq, which was approved by the FDA last June. However, the bears believe that lingering safety concerns regarding Belviq and the company’s insistence on combining the treatment with other medications could cause problems down the road. Arena shares plunged -0.44% to $6.80 in last trading session. Stock traded in range of $6.75 – $6.91.

Amgen Rating Reiterated by Goldman Sachs Group Inc. (AMGN) (WatchlistNews)
Goldman Sachs Group Inc. reiterated their buy rating on shares of Amgen, Inc. (NASDAQ:AMGN) in a research report released on Friday morning, ARN reports. A number of other firms have also recently commented on AMGN. Analysts at RBC Capital raised their price target on shares of Amgen, Inc. (NASDAQ:AMGN) from $120.00 to $125.00 in a research note to investors on Thursday, August 1st. They now have an outperform rating on the stock.

Investor’s Alert -Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Plug Power Inc (NASDAQ:PLUG), Targacept, Inc. (NASDAQ:TRGT), Inc. (NASDAQ:GTXI) (Techsonian)
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. …Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) managed to keep its gain at 1.44% on below normal -average volume of 2.71M shares. The stock settled at $7.06 after floating in a range of $6.95 to $7.13. Significantly, its latest price is at a discount of -14.25% to its 200-day moving average price.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!